Insight Molecular Diagnostics Inc. (IMDX) — Cash Flow Quality Index
Latest as of March 2023:
-2.74x
Insight Molecular Diagnostics Inc. (IMDX) has a Cash Flow Quality Index of -2.74x as of March 2023. Operating cash flow of $-8.30 Million is below net income of $3.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore IMDX operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
-2.74x
Operating CF / Net Income
Operating Cash Flow
$-8.30 Million
USD
Net Income
$3.03 Million
USD
Data as of
Mar 2023
Most recent filing
Annual Cash Flow Quality Index for Insight Molecular Diagnostics Inc. (None–None)
Year-by-year earnings quality comparison for Insight Molecular Diagnostics Inc.. For live market cap and the full company financial profile, see IMDX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.